Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Van Loon is active.

Publication


Featured researches published by J. Van Loon.


Clinical Pharmacology & Therapeutics | 1984

Platelet phenol sulfotransferase and erythrocyte catechol‐O‐methytransferase activities: Correlation with methyldopa metabolism

Norman R.C. Campbell; Joel Dunnette; G. Mwaluko; J. Van Loon; Richard M. Weinshilboum

Methyldopa is metabolized by sulfate conjugation catalyzed by phenol sulfotransferase (PST), O‐methylation catalyzed by catechol‐O‐methyltransferase (COMT), and decarboxylation catalyzed by aromatic L‐amino acid decarboxylase. These experiments were performed to determine whether individual variations in red blood cell (RBC) COMT and platelet PST activities might reflect variations in the metabolism of methyldopa in man. Methyldopa, 3.5 mg/kg, was taken orally by 28 subjects. Blood samples were obtained from these subjects for the assay of platelet PST and RBC COMT activities, and a 24‐hr urine sample was collected for the measurement of methyldopa and its major metabolites. Human platelets contain two independently regulated forms of PST. One form is thermolabile (TL), and the other is thermostable (TS). Methyldopa and α‐methyldopamine are substrates for the TL but not for the TS form of PST. The results of the experiment showed significant correlations between TL platelet PST activity and the proportion of α‐methyldopamine excreted as a sulfate conjugate, and between RBC COMT activity and the proportion of methyldopa excreted as an O‐methyl metabolite. There was no significant correlation, however, between TL platelet PST activity, and the proportion of methyldopa itself excreted as a sulfate conjugate. These results are compatible with the conclusion that differences among subjects in drug metabolizing enzyme activities are one factor responsible for wide individual variations in methyldopa metabolism in man.


Xenobiotica | 1991

Thiopurine methyltransferase regulation in rat kidney: Immunoprecipitation studies

J. S. Hernández; J. Van Loon; Diane M. Otterness; R. Guerciolini; Richard M. Weinshilboum

1. Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs. TPMT activity in the kidneys of male Sprague-Dawley (S-D) rats is approximately twice that present in the kidneys of female S-D rats, and this difference is testosterone-dependent. Renal TPMT activities in these animals also increase dramatically during growth and development. 2. Our studies were conducted to determine whether variations in TMPT activity in the S-D rat kidney were due to differences in the quantity of TPMT protein. Rabbit polyclonal antibodies to partially purified rat kidney TPMT were used to develop an immunoprecipitation assay for immunoreactive TPMT protein. 3. Gender-related differences in renal TPMT activities in S-D rats were due to a lower content of immunoreactive TPMT protein in kidneys of female animals. TPMT enzyme activities and immunoreactive protein levels were also directly correlated in renal preparations from castrated and sham-operated male rats, from testosterone-treated castrated and sham-operated male rats, and from testosterone-treated and control female rats. 4. There was also a significant positive correlation between TPMT enzymic activities and immunoreactive TPMT protein levels in renal tissue from different aged male S-D rats (rs = 0.955, n = 15, P less than 0.001.) 5. These results demonstrate that changes in S-D kidney TPMT activity during growth and development, in the two sexes and in response to testosterone, were due to variations in the quantity of immunoreactive TPMT protein.


The Lancet | 1990

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

Lynne Lennard; J. S. Lilleyman; J. Van Loon; Richard M. Weinshilboum


Drug Metabolism and Disposition | 1989

Human intestinal phenol sulfotransferase: Assay conditions, activity levels and partial purification of the thermolabile form

Rajah S Sundaram; Carol L. Szumlanski; Diane M. Otterness; J. Van Loon; Richard M. Weinshilboum


Molecular Pharmacology | 1987

Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates

Norman R.C. Campbell; J. Van Loon; Rajah S Sundaram; C. Hansch; Richard M. Weinshilboum


Drug Metabolism and Disposition | 1990

Thiopurine methyltransferase isozymes in human renal tissue.

J. Van Loon; Richard M. Weinshilboum


Journal of Pharmacology and Experimental Therapeutics | 1985

Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol

A L Kerremans; James J. Lipsky; J. Van Loon; M O Gallego; Richard M. Weinshilboum


Journal of Pharmacology and Experimental Therapeutics | 1987

Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation.

J. Van Loon; Richard M. Weinshilboum


Journal of Pharmacology and Experimental Therapeutics | 1990

Mouse thiopurine methyltransferase pharmacogenetics: correlation of immunoreactive protein and enzymatic activity.

J. S. Hernández; J. Van Loon; Diane M. Otterness; Richard M. Weinshilboum


British Journal of Clinical Pharmacology | 1983

Sulphate conjugation of p‐hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

Christoph Reiter; Peter G. Werness; J. Van Loon; L H Smith; Richard M. Weinshilboum

Collaboration


Dive into the J. Van Loon's collaboration.

Researchain Logo
Decentralizing Knowledge